Pre-money valuation for priced rounds and SAFE caps
Before you name a number in a term-sheet negotiation, know where it comes from. I build an independent pre-money valuation range for your priced round or SAFE cap, with every assumption written down so you can defend it to a lead investor or explain it to your board.
- Starting fee
- from $4,000
- Timeline
- 2 to 3 weeks
The moments that call for this work
The valuation is most useful before the first serious investor conversation, not after the term sheet arrives.
Setting a SAFE or note cap
A cap feels like a placeholder until it converts. Then it fixes your dilution. Knowing what the company is worth today, and what it may be worth at the next round, tells you whether a proposed cap is reasonable.
Leading a priced seed or Series A
Your lead will have a view on price. A documented range lets you respond to that view with evidence, and lets you judge how much room there is to negotiate.
Competing term sheets
Two offers at different prices and terms are hard to compare. Converting them to an effective value per share, after preferences and pool top-ups, shows which one is actually better.
Board or co-founder alignment
When founders, early angels and the board disagree on what to ask for, an independent range moves the discussion from opinion to assumptions.
How the number is built
For companies with some revenue, three or four methods are run in parallel and reconciled. The weighting depends on how much reliable data each method has to work with.
Starts with a credible exit value, often from revenue at exit multiplied by a sector multiple, and discounts it back at a target return that reflects stage risk. Dilution from future rounds is modelled explicitly, so the pre-money figure is not overstated.
Three cases, base, upside and downside, each with its own revenue path, exit value and probability. The weighted result is more honest than a single forecast because it puts the downside on the page.
Current or forward revenue multiplied by multiples drawn from recent private rounds and listed peers, then adjusted for growth, gross margin and retention. Used as a market cross-check rather than a stand-alone answer.
For companies with a forecast that can bear the weight, a discounted cash flow with an explicit WACC build. The discount rate is shown component by component, so anyone can see what drives it.
What you receive
- A valuation model you keep and can update before the next round
- A written report with methods, inputs, sources and the weighting stated
- A football-field chart showing every method and the concluded range
- A sensitivity grid on growth, margin and discount rate
- A dilution table showing ownership after the round and the option-pool top-up
- A live walkthrough with your board or lead investor, and 30 days of questions
What the summary looks like
| Method | Low | High | Weight |
|---|---|---|---|
| VC method | $9.5M | $14.0M | 35% |
| First Chicago | $10.2M | $13.1M | 35% |
| Revenue multiples | $8.8M | $15.6M | 30% |
| Concluded pre-money | $10.0M | $13.5M | — |
Illustrative. Figures are invented to show format only.
How the engagement runs
- 01
Scoping call to confirm the round, the investors involved and the timeline.
- 02
Fixed-fee proposal within 48 hours.
- 03
Model build with weekly check-ins. You see the draft range before the report is written.
- 04
Report, walkthrough with your board or lead, and 30 days of questions.
Questions founders ask
Can my SAFE cap stand in for a valuation?
Not reliably. A cap is a negotiated ceiling, not a measurement. It can anchor your next priced round in ways you did not intend. A valuation tells you whether the cap is defensible.
Will investors accept an independent valuation?
Investors set their own price. The point is not to dictate it but to negotiate from a documented range rather than from a single number someone else chose.
Pre-money or post-money SAFE: does it matter here?
Yes. A post-money SAFE fixes the holder's ownership and pushes dilution onto existing holders. The dilution table in the deliverables models both so you can see the difference.
Can this double as a 409A?
No. A fundraising valuation estimates enterprise or equity value for negotiation. A 409A estimates the fair market value of common stock for option pricing. They answer different questions.
What if the round price ends up outside the range?
That happens. The report shows which assumptions would need to hold for the round price to be fair, which is useful in its own right for the board.
Book a 30-minute scoping call.
Tell me what the valuation is for and who will read it. You get a fixed-fee proposal within 48 hours. No retainers.
Book a 30-min scoping callStartup Valuation Prep Checklist
The documents, data and decisions to have ready before any valuation, so the work starts on day one.